NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
What’s Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
Behnood Bikdeli/Brigham and Women's Faulkner Hospital
Aug 10, 2025, 02:59

What’s Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One

Vasculearn Network shared an inviting post on LinkedIn:

”Hope you’re soaking up summer and finding time to recharge! We’re back with the latest edition of What’s Hot In Clots, where Dr. Behnood Bikdeli’s latest reading list tackles some of the biggest questions and emerging themes in thrombosis care:

  • To thin or not to thin? After an intracranial bleed in patients with AF, the decision to restart anticoagulants is never simple. A new meta-analysis sheds light on stroke reduction vs. bleeding risks.
  • PFO and stroke: With nearly 1 in 4 people having a PFO, this JAMA review breaks down how to assess and manage cryptogenic strokes especially in patients over 60.
  • Antithrombotics and advanced cancer: A qualitative study, with a title straight from a patient’s voice, reveals powerful insights into how therapy decisions impact lives.
  • Edoxaban vs warfarin: For patients with bioprosthetic valve replacements, is anticoagulation always necessary? A new trial offers fresh perspective.”

Explore the findings and stay ahead with this month’s must-reads.

What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One

Stay informed on all upcoming webinars and conference highlights with Hemostasis Today.

AF Antithrombotics Behnood Bikdeli cancer edoxaban Health Hematology Hemostasis Today Medicine PFO stroke Vasculearn Network Warfarin What's Hot In Clots
NewsFeed